• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二酰甘油酰基转移酶1(DGAT1)可保护肿瘤免受脂毒性影响,成为一种很有前景的癌症治疗代谢靶点。

DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy.

作者信息

Cheng Xiang, Geng Feng, Guo Deliang

机构信息

Department of Radiation Oncology, James Comprehensive Cancer Center and College of Medicine at the Ohio State University, Columbus, OH, USA.

Center for Cancer Metabolism, James Comprehensive Cancer Center at the Ohio State University, Columbus, OH, USA.

出版信息

Mol Cell Oncol. 2020 Sep 8;7(6):1805257. doi: 10.1080/23723556.2020.1805257.

DOI:10.1080/23723556.2020.1805257
PMID:33235909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7671038/
Abstract

We recently demonstrated that glioblastoma, the most lethal brain cancer, upregulates diacylglycerol O-acyltransferase 1 (DGAT1) to store excess fatty acids into triglycerides to prevent lipotoxicity and promote tumor growth. Targeting DGAT1 resulted in marked tumor cell death by triggering extensive oxidative stress, indicating that DGAT1 could be a promising target for cancer therapy.

摘要

我们最近证明,最致命的脑癌——胶质母细胞瘤,会上调二酰甘油O-酰基转移酶1(DGAT1),将多余的脂肪酸储存为甘油三酯,以防止脂毒性并促进肿瘤生长。靶向DGAT1通过引发广泛的氧化应激导致显著的肿瘤细胞死亡,这表明DGAT1可能是癌症治疗的一个有前景的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/7671038/7cfacdf273cd/KMCO_A_1805257_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/7671038/7cfacdf273cd/KMCO_A_1805257_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acca/7671038/7cfacdf273cd/KMCO_A_1805257_F0001_OC.jpg

相似文献

1
DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy.二酰甘油酰基转移酶1(DGAT1)可保护肿瘤免受脂毒性影响,成为一种很有前景的癌症治疗代谢靶点。
Mol Cell Oncol. 2020 Sep 8;7(6):1805257. doi: 10.1080/23723556.2020.1805257.
2
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.靶向 DGAT1 通过增加脂肪分解和氧化应激来改善胶质母细胞瘤。
Cell Metab. 2020 Aug 4;32(2):229-242.e8. doi: 10.1016/j.cmet.2020.06.002. Epub 2020 Jun 18.
3
DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma.DGKB 通过调节 DGAT1 依赖性脂毒性来介导脑胶质瘤的放射抵抗。
Cell Rep Med. 2023 Jan 17;4(1):100880. doi: 10.1016/j.xcrm.2022.100880. Epub 2023 Jan 4.
4
Targeting DGAT1 inhibits prostate cancer cells growth by inducing autophagy flux blockage via oxidative stress.靶向 DGAT1 通过氧化应激诱导自噬通量阻断来抑制前列腺癌细胞生长。
Oncogene. 2024 Jan;43(2):136-150. doi: 10.1038/s41388-023-02878-1. Epub 2023 Nov 16.
5
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage.胶质母细胞瘤中的脂质代谢:从从头合成到储存
Biomedicines. 2022 Aug 11;10(8):1943. doi: 10.3390/biomedicines10081943.
6
Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached.DGAT1 癌蛋白抑制导致黑色素瘤中的氧化应激,当 ROS 防御也被破坏时,会抑制肿瘤生长。
Cell Rep. 2022 Jun 21;39(12):110995. doi: 10.1016/j.celrep.2022.110995.
7
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.用反义寡核苷酸抑制二酰甘油酰基转移酶-2(DGAT2)而非DGAT1,可逆转饮食诱导的肝脂肪变性和胰岛素抵抗。
J Biol Chem. 2007 Aug 3;282(31):22678-88. doi: 10.1074/jbc.M704213200. Epub 2007 May 27.
8
Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors.二酰基甘油 O-酰基转移酶 1(DGAT1)抑制剂的研究与开发现状。
J Med Chem. 2013 Dec 27;56(24):9820-5. doi: 10.1021/jm4007033. Epub 2013 Sep 3.
9
Lipid droplets and lipotoxicity during autophagy.自噬过程中的脂滴和脂毒性。
Autophagy. 2017;13(11):2002-2003. doi: 10.1080/15548627.2017.1359451. Epub 2017 Sep 21.
10
Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells.二酰基甘油酰基转移酶 2 在二酰基甘油酰基转移酶 1 的上游起作用,并在 HepG2 细胞中利用新生的二酰基甘油和从头合成的脂肪酸。
FEBS J. 2012 Sep;279(17):3033-47. doi: 10.1111/j.1742-4658.2012.08684.x. Epub 2012 Jul 31.

引用本文的文献

1
Inhibition of diacylglycerol O-acyltransferase 1 provides neuroprotection by inhibiting ferroptosis in ischemic stroke.抑制二酰甘油O-酰基转移酶1通过抑制缺血性脑卒中的铁死亡发挥神经保护作用。
Mol Med. 2025 May 15;31(1):191. doi: 10.1186/s10020-025-01255-w.
2
Radiosensitizing capacity of fenofibrate in glioblastoma cells depends on lipid metabolism.非诺贝特在胶质母细胞瘤细胞中的放射增敏能力取决于脂质代谢。
Redox Biol. 2025 Feb;79:103452. doi: 10.1016/j.redox.2024.103452. Epub 2024 Dec 2.
3
Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment.

本文引用的文献

1
Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.靶向 DGAT1 通过增加脂肪分解和氧化应激来改善胶质母细胞瘤。
Cell Metab. 2020 Aug 4;32(2):229-242.e8. doi: 10.1016/j.cmet.2020.06.002. Epub 2020 Jun 18.
2
SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy.SCAP/SREBPs 是脂质代谢中的核心调控因子,也是癌症治疗中新兴的代谢靶点。
Curr Top Med Chem. 2018;18(6):484-493. doi: 10.2174/1568026618666180523104541.
3
Lipid metabolism reprogramming and its potential targets in cancer.
靶向肿瘤干细胞的脂代谢用于癌症治疗。
Int J Mol Sci. 2024 Oct 17;25(20):11185. doi: 10.3390/ijms252011185.
4
The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications.DGAT1 和 DGAT2 在调节肿瘤细胞生长中的作用及其潜在的临床意义。
J Transl Med. 2024 Mar 18;22(1):290. doi: 10.1186/s12967-024-05084-z.
5
SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells.SREBP-1 上调脂噬作用以维持脑肿瘤细胞中的胆固醇稳态。
Cell Rep. 2023 Jul 25;42(7):112790. doi: 10.1016/j.celrep.2023.112790. Epub 2023 Jul 11.
6
The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme.《多形性胶质母细胞瘤中代谢与基因表达交汇的“超级癌基因”Myc》
Int J Mol Sci. 2023 Feb 20;24(4):4217. doi: 10.3390/ijms24044217.
7
DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma.DGKB 通过调节 DGAT1 依赖性脂毒性来介导脑胶质瘤的放射抵抗。
Cell Rep Med. 2023 Jan 17;4(1):100880. doi: 10.1016/j.xcrm.2022.100880. Epub 2023 Jan 4.
8
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage.胶质母细胞瘤中的脂质代谢:从从头合成到储存
Biomedicines. 2022 Aug 11;10(8):1943. doi: 10.3390/biomedicines10081943.
9
Metabolic Rewiring in Glioblastoma Cancer: , and Beyond.胶质母细胞瘤中的代谢重编程:现状与未来
Front Oncol. 2022 Jul 14;12:901951. doi: 10.3389/fonc.2022.901951. eCollection 2022.
10
Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth.氨刺激 SCAP/Insig 解离和 SREBP-1 激活,促进脂肪生成和肿瘤生长。
Nat Metab. 2022 May;4(5):575-588. doi: 10.1038/s42255-022-00568-y. Epub 2022 May 9.
脂质代谢重编程及其在癌症中的潜在靶点。
Cancer Commun (Lond). 2018 May 21;38(1):27. doi: 10.1186/s40880-018-0301-4.
4
Lipid droplets, potential biomarker and metabolic target in glioblastoma.脂滴,胶质母细胞瘤中的潜在生物标志物和代谢靶点。
Intern Med Rev (Wash D C). 2017 May;3(5). doi: 10.18103/imr.v3i5.443.
5
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.抑制SOAT1通过阻断SREBP-1介导的脂肪生成来抑制胶质母细胞瘤生长。
Clin Cancer Res. 2016 Nov 1;22(21):5337-5348. doi: 10.1158/1078-0432.CCR-15-2973. Epub 2016 Jun 8.
6
SCAP links glucose to lipid metabolism in cancer cells.SCAP将葡萄糖与癌细胞中的脂质代谢联系起来。
Mol Cell Oncol. 2016;3(2). doi: 10.1080/23723556.2015.1132120. Epub 2016 Jan 8.
7
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.葡萄糖介导的SCAP的N-糖基化对于SREBP-1激活和肿瘤生长至关重要。
Cancer Cell. 2015 Nov 9;28(5):569-581. doi: 10.1016/j.ccell.2015.09.021.
8
Targeting SREBP-1-driven lipid metabolism to treat cancer.靶向SREBP-1驱动的脂质代谢以治疗癌症。
Curr Pharm Des. 2014;20(15):2619-26. doi: 10.2174/13816128113199990486.
9
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.配体 X 受体激动剂通过抑制 EGFR/AKT/SREBP-1/LDLR 依赖性途径促进胶质母细胞瘤细胞死亡。
Cancer Discov. 2011 Oct;1(5):442-56. doi: 10.1158/2159-8290.CD-11-0102. Epub 2011 Sep 15.
10
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.AMPK激动剂AICAR通过抑制脂肪生成来抑制表达EGFRvIII的胶质母细胞瘤的生长。
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12932-7. doi: 10.1073/pnas.0906606106. Epub 2009 Jul 22.